After Pennsylvania began rewarding Medicaid managed care plans for increasing well-child visits among Black infants, rates ...

SMART-MASH found about a third more patients with cirrhosis than Agile 4 while using costly fibrosis tests in only some ...

Liver disease disparities tied to insurance and race spanned HCC surveillance, transplant listing, and drug access in data at ...

A population-based study of 1102 Canadian children found infants with bone and soft tissue tumors had poorer survival, driven ...

Started at advanced fibrosis or cirrhosis, pegozafermin lowered liver collagen below baseline and prevented liver cancer in a ...

ETNK1 fusion in MDS/MPN with eosinophilia; the fusion disappeared when disease relapsed as AML after transplant.

GOLD leaders say COPD is diagnosed too late and its smoking-only image is outdated, and the 2027 report puts rehab and ...

This week in health equity and access: Medicaid cuts; mailed FIT outreach; EEOC pregnancy rules; GLP-1 Bridge access; and ...

With the midterms behind them, health system leaders say coverage losses, thin margins, and payer fights are coming no matter ...

Resmetirom real-world data at The Liver Meeting 2026 show 12-month gains in liver stiffness, fat, and enzymes among patients ...

A systematic review and meta-analysis found GLP-1 RAs improved liver and metabolic markers in MASLD and MASH, but long-term ...

Most patients with CLL/SLL who discontinued a first-line BTK inhibitor did not start second-line therapy, and older age was ...